Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial

Peer Review reports

Original Submission
30 Dec 2016	Submitted	Original manuscript
5 Feb 2017	Author responded	Author comments - Juergen Behr
Resubmission - Version 2
5 Feb 2017	Submitted	Manuscript version 2
21 Mar 2017	Reviewed	Reviewer Report - Rade Tomic
1 Apr 2017	Reviewed	Reviewer Report - Giovanni Ferrara
4 May 2017	Author responded	Author comments - Juergen Behr
Resubmission - Version 3
4 May 2017	Submitted	Manuscript version 3
11 Aug 2017	Reviewed	Reviewer Report - Rade Tomic
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
23 Aug 2017	Editorially accepted
6 Sep 2017	Article published	10.1186/s12890-017-0462-y

Back to article page